Sign Up to like & get
recommendations!
1
Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10081318
Abstract: Background: Limited commercial LFA assays are available to provide a reliable quantitative measurement of the total binding antibody units (BAU/mL) against the receptor-binding domain of the SARS-CoV-2 spike protein (S-RBD). Aim: To evaluate the performance…
read more here.
Keywords:
finecaretm;
sars cov;
antibody units;
binding antibody ... See more keywords